Chemotherapy is often the only choice cancer sufferers have to regain a next-to-normal health condition. In oncology, adjuvant chemotherapy plays an important role particularly in combination with other cancer treatments. Adjuvant chemotherapy represents an additional treatment administered to the patient following a surgical intervention as a means to prevent the possible development of the cancer cells that may have remained after the removal. The patient may relapse even if surgery has been performed because unfortunately, medicine is not sufficiently developed to be able to foresee whether cancer cells will reoccur or not.
Chemical-based treatments together with radiotherapy are part of the same adjuvant chemotherapy category prescribed by doctors to stop cancer spread. Statistics indicate that about a third of the patients who have received adjuvant chemotherapy treatment have resumed good health only through surgical intervention. For those who are not included in the above mentioned third, the long term aim of the adjuvant chemotherapy is to increase the life extent of the sufferer.
Adjuvant chemotherapy works for lots of cancer typologies from colon cancer to prostrate cancer, lung, breast and pancreatic tumors.
In terms of parallel treatments, adjuvant chemotherapy is complemented by neo-adjuvant chemotherapy. The latter is given to patients before the primary treatment and it may take the form of chemical drug-based treatment. For example, neo-adjuvant chemotherapy may be prescribed to a breast-cancer patient who will have to undergo surgery for breast removal. The aim of such a type of therapy is to reduce the tumor size so that there are fewer risks and a higher rate of success in the surgical intervention.
All in all, adjuvant chemotherapy is presently considered more effective when it is prescribed after the tumor removal rather than before it because the remaining cancer cells are fewer in number and, as a result, the drug is more powerful on them. The drugs specific to this type of treatment are most efficient when they are administered directly into the blood of the patient, that is, intravenously; another way of increasing drug efficiency is to use it locally in the exact body part attacked by cancer. - 31973
Chemical-based treatments together with radiotherapy are part of the same adjuvant chemotherapy category prescribed by doctors to stop cancer spread. Statistics indicate that about a third of the patients who have received adjuvant chemotherapy treatment have resumed good health only through surgical intervention. For those who are not included in the above mentioned third, the long term aim of the adjuvant chemotherapy is to increase the life extent of the sufferer.
Adjuvant chemotherapy works for lots of cancer typologies from colon cancer to prostrate cancer, lung, breast and pancreatic tumors.
In terms of parallel treatments, adjuvant chemotherapy is complemented by neo-adjuvant chemotherapy. The latter is given to patients before the primary treatment and it may take the form of chemical drug-based treatment. For example, neo-adjuvant chemotherapy may be prescribed to a breast-cancer patient who will have to undergo surgery for breast removal. The aim of such a type of therapy is to reduce the tumor size so that there are fewer risks and a higher rate of success in the surgical intervention.
All in all, adjuvant chemotherapy is presently considered more effective when it is prescribed after the tumor removal rather than before it because the remaining cancer cells are fewer in number and, as a result, the drug is more powerful on them. The drugs specific to this type of treatment are most efficient when they are administered directly into the blood of the patient, that is, intravenously; another way of increasing drug efficiency is to use it locally in the exact body part attacked by cancer. - 31973
About the Author:
Lee writes about a variety of subjects, including fashion, such as Hello Kitty rain boots.
